You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Homologous Recombination Repair

Showing 1 - 25 of 4,423
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Homologous Recombination Repair Pathway Gene Mutation Spectrum

Not yet recruiting
  • Breast Cancer
    • (no location specified)
    Jun 4, 2023

    Solid Tumor, Adult Trial in Miami (Pembrolizumab 200 mg Q3W)

    Active, not recruiting
    • Solid Tumor, Adult
    • Pembrolizumab 200 mg Q3W
    • Miami, Florida
      Miami Cancer Institute at Baptist Health, Inc.
    Nov 18, 2022

    Hyperthermic Intraperitoneal Chemotherapy to Ovarian Cancer

    Not yet recruiting
    • Ovarian Cancer
    • HIPEC
    • (no location specified)
    Mar 2, 2022

    Cancer Trial in Melbourne (Pamiparib, Tislelizumab)

    Recruiting
    • Cancer
    • Melbourne, Victoria, Australia
      Peter MacCallum Cancer Centre
    Mar 3, 2022

    HRD and Resistance to PAPPi in EOC Patients

    Recruiting
    • Epithelial Ovarian Cancer
    • +6 more
    • Testing of homologous recombination deficiency
    • Beijing, Beijing, China
      Lei Li
    Mar 26, 2022

    mCRPC Trial in Australia, China, United States (Placebo, Senaparib)

    Not yet recruiting
    • mCRPC
    • Binghamton, New York
    • +5 more
    Dec 14, 2021

    Locally Recurrent/Metastatic Triple Negative Breast Cancer Trial in United States (radiation, drug, procedure)

    Recruiting
    • Locally Recurrent/Metastatic Triple Negative Breast Cancer
    • external beam radiation therapy
    • +2 more
    • Basking Ridge, New Jersey
    • +6 more
    Aug 8, 2022

    Advanced Cancers Trial in Boston (LY2606368)

    Active, not recruiting
    Has Results
    • Advanced Cancers
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Jan 18, 2022

    ER-positive and HER2-negative Metastatic or Locally Advanced Breast Cancer, a Germline or Somatic BRCA Mutation, or a

    Recruiting
    • ER-positive and HER2-negative Metastatic or Locally Advanced Breast Cancer
    • a Germline or Somatic BRCA Mutation, or a Deleterious Alteration of Other Genes Involved in Homologous Recombination Repair (HRR) or in MSI Status
    • Montpellier, France
    • +1 more
    Nov 16, 2022

    HRR Prevalence in LatAm PROSPECT Study

    Completed
    • Castration-resistant Prostate Cancer
      • Ciudad Autónoma de Buenos Aires, Argentina
      • +10 more
      Apr 19, 2022

      Immunotherapy Trial in France (olaparib, durvalumab, tremelimumab)

      Recruiting
      • Immunotherapy
      • olaparib, durvalumab, tremelimumab
      • Amiens, France
      • +7 more
      May 21, 2021

      Pathogenic Variants in Homologous Recombination Repair Genes in

      Completed
      • Epithelial Ovarian Cancer
      • Tumor molecular profiling
      • (no location specified)
      Jan 18, 2021

      HER2-negative Breast Cancer, Gastric Adenocarcinoma, Cholangiocarcinoma Trial in Beijing (Niraparib, Anlotinib)

      Not yet recruiting
      • HER2-negative Breast Cancer
      • +3 more
      • Beijing, Beijing, China
        Beijing Cancer Hospital
      Feb 18, 2021

      Solid Tumors, Homologous Recombination Repair Gene Mutation, Homologous Recombination Deficiency Trial in Korea, Republic of

      Recruiting
      • Solid Tumors
      • +2 more
      • Goyang, Gyeongggi-do, Korea, Republic of
      • +17 more
      Jan 20, 2022

      Ovarian Cancer Trial in Pittsburgh (Olaparib tablet)

      Not yet recruiting
      • Ovarian Cancer
      • Olaparib tablet
      • Pittsburgh, Pennsylvania
        UPMC Hillman Cancer Center
      Nov 1, 2023

      Gastric Cancer Stage IV Trial in Seoul (olaparib+pembrolizumab+paclitaxel)

      Not yet recruiting
      • Gastric Cancer Stage IV
      • Seoul, Korea, Republic of
        Severance Hospital
      Aug 29, 2021

      Locally Advanced Leiomyosarcoma, Metastatic Leiomyosarcoma, Stage III Retroperitoneal Sarcoma AJCC v8 Trial in Columbus

      Not yet recruiting
      • Locally Advanced Leiomyosarcoma
      • +6 more
      • Niraparib Tosylate Monohydrate
      • Columbus, Ohio
        Ohio State University Comprehensive Cancer Center
      Jul 25, 2022

      Pancreatic Adenocarcinoma, Homologous Recombination Deficiency Trial (Cisplatin)

      Not yet recruiting
      • Pancreatic Adenocarcinoma
      • Homologous Recombination Deficiency
      • (no location specified)
      Oct 18, 2023

      Ovarian Cancer, Epithelial Ovarian Cancer, Ovarian Cancer, Epithelial Trial in Wuhan (CRS+HIPEC, CRS alone)

      Recruiting
      • Ovarian Cancer
      • +4 more
      • CRS+HIPEC
      • CRS alone
      • Wuhan, Hubei, China
        Zhongnan Hospital of Wuhan University
      Sep 4, 2020

      Testing Circulating Tumour DNA for Homologous Recombination Gene

      Recruiting
      • Circulating Tumor DNA
      • Metastatic Prostate Cancer
      • Blood sample
      • Urine sample
      • Tours, France
        University hospital
      Sep 6, 2022

      Melanoma Trial (Fluzoparib Camrelizumab Temozolomide)

      Not yet recruiting
      • Melanoma
      • Fluzoparib Camrelizumab Temozolomide
      • (no location specified)
      Aug 9, 2023

      Homologous Recombination Deficiency Alterations Metastatic Colorectal Cancer Trial in Shanghai (Fluzoparib, Irinotecan)

      Not yet recruiting
      • Homologous Recombination Deficiency Alterations Metastatic Colorectal Cancer
      • Shanghai, Shanghai, China
        Department of Colorectal Surgery Fudan University Shanghai Caner
      Feb 22, 2023

      Homologous Recombination Inquiry Through Ovarian Malignancy

      Completed
      • Ovarian Cancer
      • +2 more
        • Niigata city, Niigata Prefecture, Japan
          Niigata University Graduate School of Medical and Dental Science
        Jan 19, 2023

        Homologous Recombination Deficiency, Triple Negative Breast Cancer Trial (Niraparib)

        Not yet recruiting
        • Homologous Recombination Deficiency
        • Triple Negative Breast Cancer
        • (no location specified)
        Jul 15, 2022

        Advanced Solid Tumors Trial in Worldwide (Olaparib)

        Recruiting
        • Advanced Solid Neoplasms
        • Tucson, Arizona
        • +128 more
        Aug 18, 2022